FDA Approves New Omega-3 Supplement

Reuters: The FDA has approved a new omega-3 supplement for the treatment of adults with severe hypertriglyceridemia, defined as triglyceride levels 500 mg/dL or higher. The drug, which will be marketed under the brand name of Epanova, is manufactured by AstraZeneca, which acquired the drug when it purchased Omthera Pharmaceuticals in 2013.

AstraZeneca said that Epanova is the first omega-3 formulation approved by the FDA in free fatty acid form. Epanova will be available in 1 gram capsules and has been approved for 2 gram and 4 gram dosages, which can be taken with or without food.

Read article